Publications
- – Health Affairs Scholar
Pre-Pandemic Assessment: A Decade of Progress in Electronic Health Record Adoption among U.S. Hospitals
Kevin Schulman is lead author on this analysis of the adoption of Electronic Health Records from 2009 to 2019, with basic adoption rising from 6.6% to 81.2%. Despite the growth, vast disparities still exist.
- – Addiction Journal
The ChatGPT therapist will see you now: Navigating generative artificial intelligence's potential in addiction medicine research and patient care
Generative AI offers potential for enhancing addiction medicine research and practice but addressing its numerous challenges is critical for its responsible adoption, writes CERC’s Jonathan Chen.
- – Health Affairs Forefront
Ensuring Access To Generic Medications In The US
CERC’s Kevin Schulman and med student Wasan Kumar write that the instability of the generic drug supply chain has reached a crisis point, with nearly 300 active drug shortages in the US at the end of 2022. The answer is to reverse the economics driving shortages.
- – Health Affairs Forefront
CBO-Health Plan Contracting Under CalAIM And The Competitive Social Care Market
Research led by Nirav Shah looks at California’s CalAIM program and offers three actions to improve the effectiveness of CBO partnerships.
- – JAMA Network Open
Review of Evidence Supporting 2022 US Food and Drug Administration Drug Approvals
Of the 37 new drugs approved by the FDA in 2022, 24 (65%) were approved based on a single study. CERC’s Bob Kaplan contributed.
- – Competition Policy International
Healthcare Administrative Costs and Competition Policy
CERC’s Kevin Schulman and Barak Richman write: “It is time for those involved in competition policy to address the specific failings in the billing market, develop structures that force a new level of standardization, and foster an architecture that invites entry and competition.”